Find disease awareness content and relevant supporting materials

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)By Nancy LapidMay 6 (Reuters) - We also report on t

These APLAR recommendations provide evidence‑ and consensus‑based guidance for managing psoriatic arthritis across the Asia‑Pacific region. They address pharmacological treatment, comorbidity management, and infection screening using GRADE‑supported evidence and regional considerations.

These CRA and SPARCC living recommendations provide contemporary guidance for the management of axial spondyloarthritis in Canada. Using a GRADE‑ADOLOPMENT approach, they address treatment, monitoring, comorbidities, and health equity, with updates planned as evidence evolves.

This ESPOGUÍA 2024 clinical practice guideline updates recommendations for the treatment of axial spondyloarthritis and psoriatic arthritis. Using the GRADE methodology, it aims to standardise care, reduce practice variability, and align management with the best available evidence.

This updated BSR guideline provides evidence‑based recommendations for the treatment of adult axial spondyloarthritis using biologic and targeted synthetic DMARDs. It addresses evolving therapeutic options, treatment strategies, and safety considerations within an increasingly complex management landscape.

These EULAR points to consider establish consensus definitions for difficult‑to‑manage and treatment‑refractory psoriatic arthritis. Developed through systematic review and expert consensus, they aim to improve patient identification and support future research and care optimisation.

These updated EULAR recommendations provide consensus guidance on the management of rheumatoid arthritis using synthetic, biologic, and targeted synthetic DMARDs. They address treatment strategies, sequencing, safety considerations, and tapering in remission based on the latest evidence.

These French SFR/SOFMER recommendations provide evidence‑based guidance for managing people living with hand osteoarthritis. They promote a multimodal, individualised approach combining non‑pharmacological and pharmacological strategies while advising against ineffective interventions.

These joint Portuguese guidelines provide clinical practice recommendations for genetic testing in inherited retinal dystrophies, emphasising the central role of molecular diagnosis. They address testing indications, counselling requirements, variant interpretation, cascade testing, and follow‑up to improve patient care and outcomes.